1-8 of 8
J. Radich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dasatinib (SPRYCEL®) in Patients (pts) with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Who Are Imatinib-Resistant (im-r) or -Intolerant (im-i): Updated Results from the CA180-015 ‘START-L’ Study.

Herve Dombret, O.G. Ottmann, G. Rosti, B. Simonsson, R.A. Larson, A. Gollerkeri, A. Apanovitch, J. Radich, Steven Coutre
Journal: Blood
Blood (2006) 108 (11): 286.
https://doi.org/10.1182/blood.V108.11.286.286
Published: 2006
Journal Articles

Gene Expression Signatures Associated with Treatment and Resistance to Imatinib Mesylate in Chronic Myeloid Leukemia Patients.

Vivian Oehler, S. Branford, E. Pogosova-Agadjanyan, N. Shah, C. Sawyers, M. Mao, P. Linsley, T. Hughes, J. Radich
Journal: Blood
Blood (2005) 106 (11): 433.
https://doi.org/10.1182/blood.V106.11.433.433
Published: 2005
Journal Articles

HLA-Matched Unrelated Donor HCT after Nonmyeloablative Conditioning for Patients with Chronic Myeloid Leukemia.

Frederic Baron, M. Maris, B. Sandmaier, B. Storer, M. Stuart, P. McSweeney, J. Radich, M. Pulsipher, E. Agura, E. Petersdorf, S. Heimfeld, T. Chauncey, M.T. Little, D. Maloney, K. Blume, R. Storb
Journal: Blood
Blood (2004) 104 (11): 2755.
https://doi.org/10.1182/blood.V104.11.2755.2755
Published: 2004
Journal Articles

Feasibility and Toxicity of Nonmyeloablative Hematopoietic Cell Transplantation (HCT) with or without Imatinib for Philadelphia Chromosome (Ph+) Acute Lymphoblastic Leukemia (ALL).

L. Norasetthada, M. B. Maris, B. M. Sandmaier, D. G. Maloney, G. Georges, B. Druker, J. Radich, R. Storb
Journal: Blood
Blood (2004) 104 (11): 5056.
https://doi.org/10.1182/blood.V104.11.5056.5056
Published: 2004
Journal Articles

Long-Term Follow-up of a Randomized Study Comparing Cyclophosphamide and Total Body Irradiation With Busulfan and Cyclophosphamide for Patients Receiving Allogeneic Marrow Transplants During Chronic Phase of Chronic Myeloid Leukemia

R.A. Clift, J. Radich, F.R. Appelbaum, P. Martin, M.E.D. Flowers, H.J. Deeg, R. Storb, E.D. Thomas
Journal: Blood
Blood (1999) 94 (11): 3960–3962.
https://doi.org/10.1182/blood.V94.11.3960a
Published: 1999
Journal Articles

Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

J.T. Slattery, R.A. Clift, C.D. Buckner, J. Radich, B. Storer, W.I. Bensinger, E. Soll, C. Anasetti, R. Bowden, E. Bryant, T. Chauncey, H.J. Deeg, K.C. Doney, M. Flowers, T. Gooley, J.A. Hansen, P.J. Martin, G.B. McDonald, R. Nash, E.W. Petersdorf, J.E. Sanders, G. Schoch, P. Stewart, R. Storb, K.M. Sullivan, E.D. Thomas, R.P. Witherspoon, F.R. Appelbaum
Journal: Blood
Blood (1997) 89 (8): 3055–3060.
https://doi.org/10.1182/blood.V89.8.3055
Published: 1997
Journal Articles

Benign marrow progenitors are enriched in the CD34+/HLA-DRlo population but not in the CD34+/CD38lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization

JA Kirk, JA Reems, BA Roecklein, DR Van Devanter, EM Bryant, J Radich, S Edmands, A Lee, B Torok-Storb
Journal: Blood
Blood (1995) 86 (2): 737–743.
https://doi.org/10.1182/blood.V86.2.737.bloodjournal862737
Published: 1995
Journal Articles

Rare occurrence of N-ras point mutations in Philadelphia chromosome positive chronic myeloid leukemia

SJ Collins, M Howard, DF Andrews, E Agura, J Radich
Journal: Blood
Blood (1989) 73 (4): 1028–1032.
https://doi.org/10.1182/blood.V73.4.1028.1028
Published: 1989